Low asparagine wheat : Europe's first field trial of genome edited wheat amid rapidly changing regulations on acrylamide in food and genome editing of crops
Copyright © 2024 by JAPANESE SOCIETY OF BREEDING.
| Veröffentlicht in: | Breeding science. - 1998. - 74(2024), 1 vom: 27. März, Seite 37-46 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , |
| Format: | Online-Aufsatz |
| Sprache: | English |
| Veröffentlicht: |
2024
|
| Zugriff auf das übergeordnete Werk: | Breeding science |
| Schlagworte: | Journal Article CRISPR acrylamide asparagine food safety precision breeding organisms processing contaminants wheat |
| Zusammenfassung: | Copyright © 2024 by JAPANESE SOCIETY OF BREEDING. We review the undertaking of a field trial of low asparagine wheat lines in which the asparagine synthetase gene, TaASN2, has been knocked out using CRISPR/Cas9. The field trial was undertaken in 2021-2022 and represented the first field release of genome edited wheat in Europe. The year of the field trial and the period since have seen rapid changes in the regulations covering both the field release and commercialisation of genome edited crops in the UK. These historic developments are reviewed in detail. Free asparagine is the precursor for acrylamide formation during high-temperature cooking and processing of grains, tubers, storage roots, beans and other crop products. Consequently, work on reducing the free asparagine concentration of wheat and other cereal grains, as well as the tubers, beans and storage roots of other crops, is driven by the need for food businesses to comply with current and potential future regulations on acrylamide content of foods. The topic illustrates how strategic and applied crop research is driven by regulations and also needs a supportive regulatory environment in which to thrive |
|---|---|
| Beschreibung: | Date Revised 10.09.2024 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
| ISSN: | 1344-7610 |
| DOI: | 10.1270/jsbbs.23058 |